chartexchange

ANAB270115P00025000
ANAB Jan 15 2027 25.00 Put
optionOPRA

EOD
—USD
Loading…
Underlying
Underlying Price
$47.40
Type
Put
Strike
25
Expiration
Jan 15, 2027
DTE
57d
Moneyness
OTM
Intrinsic
$0.00
ANAB 25 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Nov 20, 20261d$0.90+5.88%112
Dec 18, 202629d——00
Jan 15, 202757d——00
Feb 19, 202792d$1.70-15.00%134
May 21, 2027183d$1.00-45.95%1765
ANAB Nearby Strikes · Jan 15, 2027
StrikeLastChangeVolOpen IntMoneyness
25 P——00OTM
30 P——00OTM
35 P——00OTM
40 P——00OTM
45 P——00OTM
50 P——00ITM
55 P——00ITM
ANAB Profile

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio's proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c